Single nucleotide polymorphisms in genes encoding LKB1 (STK11), TORC2 (CRTC2) and AMPK α2-subunit (PRKAA2) and risk of type 2 diabetes

Molecular Genetics and Metabolism

Volumn 93, Issue 2, 2008, Pages 200-209

  Keshavarz, Parvaneh ^a,b   Inoue, Hiroshi ^a   Nakamura, Naoto ^c   Yoshikawa, Toshikazu ^c   Tanahashi, Toshihito ^a   Itakura, Mitsuo ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Adenosine 5 monophosphate activated protein kinase; Case control association study; CRTC2; PRKAA2; Single nucleotide polymorphism; STK11; Type 2 diabetes

Indexed keywords

ADENYLATE KINASE; ANTIDIABETIC AGENT; CHOLESTEROL; CRTC2 PROTEIN; PROTEIN KINASE LKB1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENE INTERACTION; GENETIC CODE; GENETIC MODEL; GENETIC SCREENING; GENETIC VARIABILITY; GLUCOSE HOMEOSTASIS; HAPLOTYPE; HUMAN; INTRON; JAPANESE; MAJOR CLINICAL STUDY; MALE; MOLECULAR INTERACTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; JAPAN; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MULTIENZYME COMPLEXES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RISK FACTORS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 38049067500     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2007.08.125     Document Type: Article

References (27)

1. Kahn B.B., Alquier T., Carling D., and Hardie D.G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 1 (2005) 15-25
2. Kola B., Boscaro M., Rutter G.A., Grossman A.B., and Korbonits M. Expanding role of AMPK in endocrinology. Trends Endocrinol. Metab. 17 (2006) 205-215
3. Long Y.C., and Zierath J.R. AMP-activated protein kinase signaling in metabolic regulation. J. Clin. Invest. 116 (2006) 1776-1783
4. Villena J.A., Viollet B., Andreelli F., Kahn A., Vaulont S., and Sul H.S. Induced adiposity and adipocyte hypertrophy in mice lacking the AMP-activated protein kinase-alpha2 subunit. Diabetes 53 (2004) 2242-2249
5. Viollet B., Andreelli F., Jørgensen S.B., Perrin C., Geloen A., Flamez D., Mu J., Lenzner C., Baud O., Bennoun M., Gomas E., Nicolas G., Wojtaszewski J.F., Kahn A., Carling D., Schuit F.C., Birnbaum M.J., Richter E.A., Burcelin R., and Vaulont S. The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. J. Clin. Invest. 111 (2003) 91-98
6. Carling D. LKB1: a sweet side to Peutz-Jeghers syndrome?. Trends Mol. Med. 12 (2006) 144-147
7. Shaw R.J., Lamia K.A., Vasquez D., Koo S.H., Bardeesy N., Depinho R.A., Montminy M., and Cantley L.C. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310 (2005) 1642-1646
8. Koo S.H., Flechner L., Qi L., Zhang X., Screaton R.A., Jeffries S., Hedrick S., Xu W., Boussouar F., Brindle P., Takemori H., and Montminy M. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437 (2005) 1109-1111
9. Kahn S.E. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 46 (2003) 3-19
10. Mori Y., Otabe S., Dina C., Yasuda K., Populaire C., Lecoeur C., Vatin V., Durand E., Hara K., Okada T., Tobe K., Boutin P., Kadowaki T., and Froguel P. Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate Loci on 7p and 11p. Diabetes 51 (2002) 1247-1255
11. Du W., Sun H., Wang H., Qiang B., Shen Y., Yao Z., Gu J., Xiong M., Huang W., Chen Z., Zuo J., Hua X., Gao W., Sun Q., and Fang F. Confirmation of susceptibility gene loci on chromosome 1 in northern China Han families with type 2 diabetes. Chin. Med. J. 114 (2001) 876-878
12. Malhotra A., and Wolford J.K. Analysis of quantitative lipid traits in the genetics of NIDDM (GENNID) study. Diabetes 54 (2005) 3007-3014
13. McCarthy M.I. Growing evidence for diabetes susceptibility genes from genome scan data. Curr. Diab. Rep. 3 (2003) 159-167
14. Das S.K., and Elbein S.C. The search for type 2 diabetes susceptibility Loci: the chromosome 1q story. Curr. Diab. Rep. 7 (2007) 154-164
15. Sun M.W., Lee J.Y., de Bakker P.I., Burtt N.P., Almgren P., Rastam L., Tuomi T., Gaudet D., Daly M.J., Hirschhorn J.N., Altshuler D., Groop L., and Florez J.C. Haplotype structures large-scale association testing of the 5AMP-activated protein kinase genes PRKAA2 PRKAB1 and PRKAB2 with type 2 diabetes. Diabetes 55 (2006) 849-855
16. Horikoshi M., Hara K., Ohashi J., Miyake K., Tokunaga K., Ito C., Kasuga M., Nagai R., and Kadowaki T. A polymorphism in the AMPKalpha 2 subunit gene is associated with insulin resistance and type 2 diabetes in the Japanese population. Diabetes 55 (2006) 919-923
17. Keshavarz P., Inoue H., Sakamoto Y., Kunika K., Tanahashi T., Nakamura N., Yoshikawa T., Yasui N., Shiota H., and Itakura M. No evidence for association of the ENPP1 (PC-1) K121Q variant with risk of type 2 diabetes in a Japanese population. J. Hum. Genet. 51 (2006) 559-566
18. Tanahashi T., Osabe D., Nomura K., Shinohara S., Kato H., Ichiishi E., Nakamura N., Yoshikawa T., Takata Y., Miyamoto T., Shiota H., Keshavarz P., Yamaguchi Y., Kunika K., Moritani M., Inoue H., and Itakura M. Association study on chromosome 20q11.21-13.13 locus its contribution to type 2 diabetes susceptibility in Japanese. Hum. Genet. 120 (2006) 527-542
19. Dupont W.D., and Plummer W.D. Power and sample size calculations for studies involving linear regression. Control. Clin. Trials 19 (1998) 589-601
20. Storey J.D., and Tibshirani R. Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. USA 100 (2003) 9440-9445
21. Macgregor S., and Khan I.A. GAIA: an easy-to-use web-based application for interaction analysis of case-control data. BMC Med. Genet. 7 (2006) 34-39
22. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., Higgins J., DeFelice M., Lochner A., Faggart M., Liu-Cordero S.N., Rotimi C., Adeyemo A., Cooper R., Ward R., Lander E.S., Daly M.J., and Altshuler D. The structure of haplotype blocks in the human genome. Science 296 (2002) 2225-2229
23. Johnson G.C., Esposito L., Barratt B.J., Smith A.N., Heward J., Di Genova G., Ueda H., Cordell H.J., Eaves I.A., Dudbridge F., Twells R.C., Payne F., Hughes W., Nutland S., Stevens H., Carr P., Tuomilehto-Wolf E., Tuomilehto J., Gough S.C., Clayton D.G., and Todd J.A. Haplotype tagging for the identification of common disease genes. Nat. Genet. 29 (2001) 233-237
24. Goddard K.A., Hopkins P.J., Hall J.M., and Witte J.S. Linkage disequilibrium and allele-frequency distributions for 114 single-nucleotide polymorphisms in five populations. Am. J. Hum. Genet. 66 (2000) 216-234
25. Newton-Cheh C., and Hirschhorn J.N. Genetic association studies of complex traits: design and analysis issues. Mutat. Res. 573 (2005) 54-69
26. Spencer-Jones N.J., Ge D., Snieder H., Perks U., Swaminathan R., Spector T.D., Carter N.D., and O'Dell S.D. AMP-kinase alpha2 subunit gene PRKAA2 variants are associated with total cholesterol low-density lipoprotein-cholesterol and high-density lipoprotein-cholesterol in normal women. J. Med. Genet. 43 (2006) 936-942
27. Ritchie M.D., Hahn L.W., Roodi N., Bailey L.R., Dupont W.D., Parl F.F., and Moore J.H. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am. J. Hum. Genet. 69 (2001) 138-147